| __timestamp | Travere Therapeutics, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47795223 | 581800000 |
| Thursday, January 1, 2015 | 50426000 | 671900000 |
| Friday, January 1, 2016 | 70853000 | 876700000 |
| Sunday, January 1, 2017 | 78168000 | 857900000 |
| Monday, January 1, 2018 | 123757000 | 822200000 |
| Tuesday, January 1, 2019 | 140963000 | 778200000 |
| Wednesday, January 1, 2020 | 131773000 | 512600000 |
| Friday, January 1, 2021 | 210328000 | 681000000 |
| Saturday, January 1, 2022 | 235780000 | 662200000 |
| Sunday, January 1, 2023 | 244990000 | 910700000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, innovation is key. Over the past decade, Viatris Inc. and Travere Therapeutics, Inc. have shown distinct strategies in their research and development (R&D) investments. From 2014 to 2023, Viatris consistently outpaced Travere, investing nearly three times more in R&D annually. In 2023, Viatris allocated approximately 910 million dollars, marking a 56% increase from 2014. Meanwhile, Travere's R&D spending grew by over 400%, reaching around 245 million dollars in 2023. This significant growth highlights Travere's commitment to innovation, despite its smaller scale. The data underscores a broader trend: while larger firms like Viatris maintain substantial R&D budgets, smaller companies like Travere are rapidly increasing their investments, potentially reshaping the industry's future. This dynamic shift in R&D spending patterns is crucial for stakeholders aiming to understand the evolving pharmaceutical landscape.
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Viatris Inc.
R&D Spending Showdown: Genmab A/S vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
Viatris Inc. or ImmunityBio, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Viatris Inc. or MannKind Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Xenon Pharmaceuticals Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.
R&D Insights: How Travere Therapeutics, Inc. and MiMedx Group, Inc. Allocate Funds